Twin Tree Management
RPRX icon

Twin Tree Management’s Royalty Pharma RPRX Stock Holding History

Twin Tree Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-900
Closed -$28K – 1884
2025
Q1 		$28K Buy
+900
New +$28.5K ﹤0.01% 1476
2022
Q1 		– Sell
-19,800
Closed -$789K – 1864
2021
Q4 		$789K Buy
+19,800
New +$769K ﹤0.01% 1280

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Twin Tree Management's RPRX Position: Q2 2025 in Review

Twin Tree Management sold out of Royalty Pharma (RPRX) in Q2 2025, closing a stake of 44,763 shares — an estimated $1.48M sold.

Twin Tree Management first reported a position in RPRX in Q2 2022 and held it in 8 quarters. The position peaked at $2.79M in Q1 2024. 455 funds tracked by Wall St. Rank hold RPRX as of Q2 2025.

  • Twin Tree Management reported no remaining Royalty Pharma position as of Q2 2025 after selling out during the quarter.
  • Twin Tree Management sold 44,763 Royalty Pharma shares in Q2 2025, an estimated $1.48M.
  • Twin Tree Management first reported a position in Royalty Pharma in Q2 2022 and held it in 8 quarters.
  • Twin Tree Management's Royalty Pharma position peaked at $2.79M in Q1 2024.
  • 455 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.